Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qianlie Bi'ertong suppository in chronic nonbacterial prostatitis (damp-heat and blood stasis pattern)
CTR20230390Phase 2Completed
- Sponsor
- Heilongjiang Jiren Pharmaceutical
- Start
- Mar 2023
- Countries
- 1
01
Overview
A Phase 2 trial of Qianlie Biertong in Prostatodynia (CP/CPPS), sponsored by Heilongjiang Jiren Pharmaceutical. Started Mar 2023; status: completed.
02
Drugs
Qianlie Biertong
03
Conditions
Prostatodynia (CP/CPPS)
Beyond the preview
Go deeper on CTR20230390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230390.